BackCTI BioPharma Overview

CTI BioPharma Intangible Assets

CTI BioPharma's intangible assets is $23M.

Get informed when a big investor buys or sells

+ Follow
Intangible Assets
$22.70M
↓ 8.50% YoYΔ $-2.11M vs prior year quarter

Peer average

Loading

CTI BioPharma Intangible Assets History

Loading

CTI BioPharma vs. peers: Intangible Assets Comparison

Loading

CTI BioPharma Intangible Assets Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

CTI BioPharma (CTIC) FAQ

The latest intangible assets for CTIC is $23M as of March 2023. That compares with $25M in the prior-year period — down 8.5% year over year. Investors often review this figure alongside CTI BioPharma's historical trend and sector peers before judging valuation or financial health.

Over the past year, CTIC's intangible assets moved from $25M to $23M — a 8.5% year-over-year decrease. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in CTI BioPharma's operating scale or balance-sheet position.

A intangible assets figure of $23M for CTIC is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. Explore the charts below for those layers of context.

After noting CTIC's intangible assets ($23M), review year-over-year change from $25M, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.

This page's peer comparison chart is the fastest way to stack CTI BioPharma's intangible assets against similar Healthcare names. You can also browse sector and industry screens on Stockcircle for a broader set of Healthcare companies and their key multiples and fundamentals.